CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2006-09-26): WHO approves new child vaccine

Regulatory

WHO approves new child vaccine

Last Updated: 2006-09-26 13:27:02 -0400 (Reuters Health)

AMSTERDAM (Reuters) - The World Health Organization (WHO) gave Dutch biotech firm Crucell the green light on Tuesday to start selling a new vaccine for protection against five major childhood diseases.

The vaccine, Quinvaxem, offers protection against diphtheria, tetanus, whooping cough, hepatitis B and Haemophilus influenzae type b.

Crucell said in a statement that WHO's decision to grant "prequalification" meant it could start selling Quinvaxem to aid organisations UNICEF and PAHO, the Pan American Health Organisation.

Crucell estimates the current demand for the Quinvaxem vaccine at more than 50 million doses, with annual demand expected to increase to more than 150 million per year over the next five years.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.